资讯

The Week is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.
Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital therapeutic (DTx) for amblyopia or lazy eye in children that is based on watching TV shows.
njmu.edu.cn and Professor Chen-Wei Pan, Medical College of Soochow University, Suzhou, China; pcwonly{at}gmail.com Purpose Amblyopia is a leading cause of vision impairment among children and young ...
The largest amblyopia treatment registry to-date, the PUPiL Registry uses an all-comers' design to evaluate real-world outcomes in a representative population. It's comprised of more than 500 ...
Aravind Eye Hospital, Coimbatore, has opened a state-of-the-art Amblyopia and Binocular Vision Clinic, supported by BYNOCS, a global leader in AI-based digital therapies for vision. Dr.
Previously approved 1 for children aged 4 to 7 years, Luminopia's innovative amblyopia treatment is backed by multiple clinical trials and real-world evidence and is now cleared for a wider patient ...
FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 ...
FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21 ...